"The offshore money printer" reappears! COSCO Shipping Holdings expects its annual net profit attributable to the parent to double year-on-year | Quick read announcement.
① COSCO Shipping Holdings' container shipping business achieved growth in both volume and price compared to the previous year, with a year-on-year increase of 105.71% in Net income for 2024; ② One of the uncertainties in the shipping market for 2025, the strike at the East Coast ports of the United States, has been avoided, and freight rates on the US routes have already decreased.
Volume increases and prices remain low as the express delivery industry competes to reduce costs. The application of autonomous vehicles and Drones is expected to accelerate next year | Year-end review.
① Since the beginning of the year, the growth rate of express delivery volume has exceeded 20%; the operating situation of "the two logistics giants and one delivery company" in the first 11 months shows volume increase and low prices, with ZTO achieving year-on-year revenue growth per package in Q3. ② Industry insiders say that the growth rate of express delivery volume will still be double-digit in the next 1-2 years. It is expected that next year, Drones and unmanned vehicles will accelerate their application in various express delivery scenarios, further reducing social Logistics costs.
Cosco Ship Engy welcomes Taibao's shareholding, frequent institutions' shareholding within the year.
Cosco Ship Engy (1138.HK) received further shareholding. On December 5th, China Pacific Insurance (601601.SH) disclosed that as of November 29th...
China Pacific Insurance announced a stake in cosco ship engy listed in hong kong. Since November, there have been 7 instances of insurance capital acquiring stakes, possibly preparing for asset allocation next year.
① china pacific insurance announced that it has acquired shares in cosco ship engy listed in hong kong, with the company and its associates and concerted parties collectively holding 5.04%; ② china pacific insurance indicated that it does not rule out the possibility of further investment in the future; ③ insurance capital's enthusiasm for acquiring shares has increased towards the end of the year, with a total of 7 acquisitions since November, and industry insiders believe that insurance companies are beginning to prepare for asset allocation for next year.
CERo Therapeutics Presents Preclinical Data At SITC 2024 Showing CER-1236 Effectively Kills Ovarian Cancer Cells Without Toxicity In Animal Models
Compass Therapeutics Presents Biomarker Data Related To CTX-471 Clinical Activity At SITC Annual Meeting